Sherri Ozawa, MSN, RN, told The Post that serious blood loss during menstruation could be a symptom of a blood disorder that compromises the body’s ability to form blood clots.

It works by blocking a protein that stimulates platelets (blood components that help with normal clotting) to form a clot in response to bleeding. Like all drugs that interfere with blood clotting ...

Bentracimab restored platelet function in patients on ticagrelor with major bleeding or undergoing urgent surgery. Bentracimab is an intravenous monoclonal antibody. Perspective from Grant Reed ...

The following is a summary of "Bleeding Risk Assessment with Thromboelastography in Interventional Pulmonology Procedures," ...

A BLA has been filed for bentracimab and, if approved, has the potential to be the first therapy to reverse the effects of ...

25). The antidote, bentracimab, rapidly restored normal platelet function in ticagrelor-treated patients. This was true for both surgical patients and those with major bleeding. Most patients in ...

Late-breaking data showed almost all patients achieved normal blood clotting and vessel repair after bentracimab infusion.

The FDA has granted orphan drug designation to rilzabrutinib for IgG4-related disease and warm autoimmune hemolytic anemia, ...